Substance / Medication

Apraclonidine

Overview

Active Ingredient
apraclonidine
RxNorm CUI
14845

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
TOPICAL APRACLONIDINE REDUCES PAIN AFTER INTRAVITREAL INJECTIONS: A Double-Blind Randomized Controlled Trial.
Lagstein Oded, Ben-Artzi Noa, Achiron Asaf et al. · Retina · 2017
PMID: 27841849RCT
Pupillometry study of brimonidine tartrate 0.2% and apraclonidine 0.5%.
Besada Eulogio, Reed Kimberly, Najman Perla et al. · J Clin Pharmacol · 2011
PMID: 21406599RCT
Apraclonidine and LASIK.
Aslanides Ioannis M, Tsiklis Nikolaos S, Pallikaris Ioannis G et al. · Ophthalmology · 2005
PMID: 16325717RCT
Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial.
Agha Mohamad, Ismail Helen, Sawaya Raja et al. · Muscle Nerve · 2023
PMID: 37259693Trial
Apraclonidine and my pupil.
Cambron Melissa, Maertens Heidi, Crevits Luc · Clin Auton Res · 2011
PMID: 21384091Trial
Brimonidine and apraclonidine as vasoconstrictors in adjustable strabismus surgery.
Dahlmann-Noor Annegret H, Cosgrave Edel, Lowe Stuart et al. · J AAPOS · 2009
PMID: 19393510Trial
Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine.
Kasetti Savitha R, Desai Shrivatsa P, Sivakumar Subramaniam et al. · J Cataract Refract Surg · 2002
PMID: 12498856Trial
Dorzolamide X apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy.
Arieta Carlos, Amaral Marcela, Matuda Eliana et al. · Curr Eye Res · 2002
PMID: 12658557Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Apraclonidine (substance)
SNOMED CT
391786008
UMLS CUI
C0048038
RxNorm CUI
14845

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Apraclonidine: Uses, Evidence & Side Effects | Ltrl